NHS to experiment with 12-cancer-detecting blood test for potential implementation
⚡️ New-Age Cancer Detection: Revolutionizing Early Diagnosis ⚡️
The healthcare landscape is witnessing a significant shift with the advent of groundbreaking blood tests augmented by AI technology. These innovative tests are on the verge of revolutionizing cancer detection, providing hope for earlier diagnosis and improved treatment outcomes. Let's dive into the exciting world of these advanced tests.
🔥 Powerful Performance 🔥
Tests like the miONCO-Dx, currently being tested on 8,000 NHS patients, have shown remarkable accuracy in detecting cancer. Preliminary reports indicate a whopping 99% accuracy in identifying various cancer types and localizing them within the body. It's just a matter of 10 drops of blood to diagnose up to 12 common cancers, including gastric, prostate, ovarian, and pancreatic cancers, among others [1].
🔥 Cancer Hunting: A Few Drops Away 🔥
These blood tests look for tiny genetic material fragments released by tumors in blood samples. The ability to detect cancer at such an early stage allows for a diagnosis when the disease is far more treatable [2].
🔥 The Future is Bright 🔥
The Department of Health has recognized the potential of these tests and has awarded £2.4m to run a trial of this genetic test, which was developed by the University of Southampton and the biotech startup Xgenera. This validation and verification stage will be crucial in determining the effectiveness of the test for practical use [3].
🔥 Remembering a Champion 🔥
In conjunction with this development, a laboratory has recently been renamed in memory of bowel cancer campaigner Dame Deborah James, who passed away from the disease at the age of 40. The Bowelbabe lab, funded by Cancer Research UK, will focus on research for the second most common cause of cancer deaths in the country [4].
~~~~~~~~~~~~~~~~~~~~~~~~
[1] https://www.bbc.com/news/health-62334372[2] https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2022-01-19-new-test-that-aims-to-spot-hidden-cancers-in-blood-for-earlier-diagnosis-and-better-outcomes-launched-in-uk-trial[3] https://www.edhubble.com/articles/news/ai-is-revolutionizing-cancer-diagnosis-and-treatment[4] https://www.mirror.co.uk/news/uk-news/new-blood-test-aims-spot-27047749[5] https://www.worldmedicalinnovationfestival.com/news/the-race-to-develop-a-universal-cancer-test-is-on
Stay informed with the latest updates:
🔗 Follow Us
Breaking News!
👊 MMA Fighter's 15-Year Jail Sentence 👊🎤 Country Star Seeks Pardon from Criminal Past 🎤🕰️ What are the Chances of a British Pope? 🕰️
📱 Be the first to get Breaking News! 📱
Install our website app now! 📱📱📱
- The miONCO-Dx, currently being tested on 8,000 NHS patients, shows exceptional accuracy in detecting various cancer types, reaching up to 99%, even in the early stages of diseases like gastric, prostate, ovarian, and pancreatic cancers.
- The innovative blood tests, such as the one offered by miONCO-Dx, are designed to analyze tiny genetic material fragments released by tumors, providing an opportunity for early detection and improved treatment outcomes.
- In health and wellness, the advancements in science, such as the creation of the miONCO-Dx, are revolutionizing cancer diagnosis, offering hope for earlier diagnoses and better health outcomes for those facing medical-conditions like cancer.
- A laboratory has been named in memory of bowel cancer campaigner Dame Deborah James, who passed away from the disease at the age of 40. The Bowelbabe lab, funded by Cancer Research UK, will focus on research to combat the second most common cause of cancer deaths in the country.
- The development of universal cancer tests, like the miONCO-Dx, is gaining momentum as science continues to analyze and address symptoms and the unique nature of various cancers, potentially transforming the face of healthcare and wellness in the future.
